Your Messages Inbox
Your Article Summary
See Latest ArticlesCV Therapeutics and Astellas Announce FDA Approval for Lexiscan (regadenoson) Injection
Astellas, 09/11/09
CV Therapeutics, Inc. and Astellas Pharma US, Inc. announced that the U.S. Food and Drug Administration has approved Lexiscan injection, an A2A adenosine receptor agonist, for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging– a test that detects and characterizes coronary artery disease– in patients unable to undergo adequate exercise stress.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor